Close

MYGN Financial Facts

Other: -140K
Operating income: 41.47M
See Full Income Statement

Total assets: 611.74M
Accumulated deficit: -38.3M
See Full Balance Sheet

Myriad Genetics Inc. (MYGN) Earnings

  |   Expand Research on MYGN
Next EPS Date N/A EPS Growth Rate N/A
Average EPS % Beat Rate +72.6% Revenue Growth Rate N/A
Average % Move 1-Wk after EPS -1.3% Normal Earnings Time Before Open
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
8/2/22 Q222 N/A$0.03 N/A N/A$172.12M N/A N/A N/A
8/3/21 Q421 $0.12-$0.09 +$0.21$189.4M$165.4M N/A Details
11/2/21 Q321 -$0.02-$0.02 $0.00$167.3M$165.04M N/A Details
5/3/21 Q321 -$0.06-$0.14 +$0.08$173.1M$156.2M N/A Details
2/23/21 Q221 -$0.12-$0.12 $0.00$154.6M$150.39M N/A Details
11/9/20 Q121 -$0.15-$0.30 +$0.15$145.2M$135.21M N/A Details
8/13/20 Q420 -$0.31-$0.47 +$0.16$93.2M$93.85M N/A Details
5/5/20 Q320 -$0.08$0.02 -$0.10$164M$167.19M N/A Details